PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Apr-2023 Teeth Whitening Market is estimated to reach US$ 10.7 billion by 2032, with a 4.9% CAGR | FMI MARKITWIRED
18-Apr-2023 GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health Businesswire
18-Apr-2023 TME Pharma Publishes Unaudited Financial Results for Fiscal Year 2022 Businesswire
18-Apr-2023 Advancing Precision Care: GE HealthCare Introduces an Innovative Solution to Help Expand Interventional CT Access Businesswire
18-Apr-2023 Survey Confirms an Overwhelming Majority of Americans Want the Flexibility to Use Pre-Tax Dollars to Purchase Nutritional Supplements for Better Health Businesswire
18-Apr-2023 Fuse Medical, Inc. Fiscal Year 2022 Financial Results Businesswire
18-Apr-2023 LexisNexis Risk Solutions Appoints Adam Mariano as President and General Manager of Healthcare Businesswire
18-Apr-2023 Abivax appoints Michael Ferguson as Chief Commerical Officer ABIVAX
18-Apr-2023 Rootstock Software Extinguishes Inefficiency for Premier Fire Protection Equipment Manufacturer with New Cloud ERP Solution Businesswire
18-Apr-2023 PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego Businesswire
18-Apr-2023 Genexa Receives Its First Patent for Agave-Based Medicines Businesswire
18-Apr-2023 Orum Therapeutics Unveils New Program at AACR 2023, Highlighting Cbl-b Inhibitor-PD-1 Conjugate, and Presents New Data Supporting Clinical Development of Two GSPT1 Programs Businesswire
18-Apr-2023 Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares Gerresheimer AG
18-Apr-2023 First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant Businesswire
18-Apr-2023 MAIA Biotechnology Announces Excellent Efficacy of THIO in Liver Cancer Models Businesswire
18-Apr-2023 Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares Gerresheimer AG
18-Apr-2023 Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting Evolva Holding SA
18-Apr-2023 Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses Businesswire
18-Apr-2023 NorthStar Medical Radioisotopes Expands Management Team with Appointment of Jean-Noel David, MBA, MS, as Vice President, Operations Businesswire
18-Apr-2023 Autobahn Therapeutics Advances ABX-002, its Lead Oral Treatment for Major Depressive Disorder, into Multi-Ascending Dose Portion of Phase 1 Trial Businesswire